Mikov M - Search Results

1

Population exposure-response model of ¹³¹I in patients with benign thyroid disease.

Topić Vučenović V, Rajkovača Z, Jelić D, Stanimirović D, Mikov M, Miljković B, Vučićević K. Topić Vučenović V, et al. Among authors: mikov m. Eur J Pharm Sci. 2021 Oct 1;165:105942. doi: 10.1016/j.ejps.2021.105942. Epub 2021 Jul 14. Eur J Pharm Sci. 2021. PMID: 34273482

2

Retention data of bile acids and their oxo derivatives in characterization of pharmacokinetic properties and in silico ADME modeling.

Trifunović J, Borčić V, Vukmirović S, Kon SG, Mikov M. Trifunović J, et al. Among authors: mikov m. Eur J Pharm Sci. 2016 Sep 20;92:194-202. doi: 10.1016/j.ejps.2016.07.011. Epub 2016 Jul 14. Eur J Pharm Sci. 2016. PMID: 27423261

3

The Effect of Hypoalbuminemia on the Therapeutic Concentration and Dosage of Vancomycin in Critically Ill Septic Patients in Low-Resource Countries.

Kovacevic T, Miljkovic B, Mikov M, Stojisavljevic Satara S, Dragic S, Momcicevic D, Kovacevic P. Kovacevic T, et al. Among authors: mikov m. Dose Response. 2019 May 20;17(2):1559325819850419. doi: 10.1177/1559325819850419. eCollection 2019 Apr-Jun. Dose Response. 2019. PMID: 31205457 Free PMC article.

4

Do We Bury Antibacterials When Launching? Cefaclor Example.

Tomić Z, Tomas A, Vukmirović S, Mikov M, Horvat O, Tomić N, Sabo A. Tomić Z, et al. Among authors: mikov m. J Pharm Sci. 2016 Mar;105(3):1295-300. doi: 10.1016/j.xphs.2015.12.003. Epub 2016 Jan 30. J Pharm Sci. 2016. PMID: 26886327

5

Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects.

Mathavan S, Mikov M, Golocorbin-Kon S, Al-Salami H. Mathavan S, et al. Among authors: mikov m. Eur J Pharm Sci. 2017 Aug 30;106:1-9. doi: 10.1016/j.ejps.2017.05.041. Epub 2017 May 19. Eur J Pharm Sci. 2017. PMID: 28529037

6

PAMPA model of gliclazide permeability: The impact of probiotic bacteria and bile acids.

Đanić M, Pavlović N, Stanimirov B, Lazarević S, Vukmirović S, Al-Salami H, Mikov M. Đanić M, et al. Among authors: mikov m. Eur J Pharm Sci. 2021 Mar 1;158:105668. doi: 10.1016/j.ejps.2020.105668. Epub 2020 Dec 7. Eur J Pharm Sci. 2021. PMID: 33301903

7

Docking-based preliminary study on the interactions of bile acids with drugs at the transporter level in intestinal bacteria.

Djanic M, Pavlovic N, Stanimirov B, Stojancevic T, Golocorbin-Kon S, Bojic G, Mikov M. Djanic M, et al. Among authors: mikov m. Eur Rev Med Pharmacol Sci. 2016;20(3):553-60. Eur Rev Med Pharmacol Sci. 2016. PMID: 26914133 Free article.

8

Impact of Novel Teflon-DCA Nanogel Matrix on Cellular Bioactivity.

Kovacevic B, Ionescu CM, Wagle SR, Jones M, Lewkowicz M, Wong EYM, Đanić M, Mikov M, Mooranian A, Al-Salami H. Kovacevic B, et al. Among authors: mikov m. J Pharm Sci. 2023 Mar;112(3):700-707. doi: 10.1016/j.xphs.2022.09.008. Epub 2022 Sep 21. J Pharm Sci. 2023. PMID: 36150468

9

Consumption of serum lipid-reducing drugs in Serbia compared with Scandinavian countries: a population-based study, 2004-2008.

Sabo A, Tomić Z, Stilinović N, Milijašević B, Mikov M, Vukmirović S, Horvat O. Sabo A, et al. Among authors: mikov m. Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):45-9. doi: 10.1002/pds.2045. Pharmacoepidemiol Drug Saf. 2011. PMID: 20938914

10

Analgesic effects of rosemary essential oil and its interactions with codeine and paracetamol in mice.

Raskovic A, Milanovic I, Pavlovic N, Milijasevic B, Ubavic M, Mikov M. Raskovic A, et al. Among authors: mikov m. Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):165-72. Eur Rev Med Pharmacol Sci. 2015. PMID: 25635991 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

228 results

Search Page